Short report: Limited advantage of multiple consecutive samples for genotyping Plasmodium falciparum populations during the first days of treatment

American Journal of Tropical Medicine and Hygiene

Volumn 73, Issue 1, 2005, Pages 204-206

  Färnert, Anna ^a   Björkman, Anders ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; MEFLOQUINE; PROGUANIL; PROTOZOAL DNA; QUININE; MEROZOITE SURFACE PROTEIN 1; MEROZOITE SURFACE PROTEIN 2, PLASMODIUM; PARASITE ANTIGEN; PROTOZOAL PROTEIN;

ADULT; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; GENOTYPE; HUMAN; MALARIA; MALARIA FALCIPARUM; NONHUMAN; PARASITEMIA; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; ANIMAL; GENETICS; ISOLATION AND PURIFICATION;

PLASMODIUM FALCIPARUM;

ANIMALS; ANTIGENS, PROTOZOAN; ANTIMALARIALS; GENOTYPE; HUMANS; MALARIA, FALCIPARUM; MEROZOITE SURFACE PROTEIN 1; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS;

EID: 24644451568     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2005.73.204     Document Type: Article

References (13)

1. World Health Organization, 2002. Monitoring Antimalarial Drug Resistance: Report of a WHO Consultation. Geneva: World Health Organization. December 3-5, 2001. WHO/CDS/CSR/EPH/2002.17.
2. Snounou G, Beck HP, 1998. The use of PCR genotyping in the assessment of recrudescence or reinfection after antimalarial drug treatment. Parasitol Today 14: 462-467.
3. Magesa SM, Mdira KY, Farnert A, Simonsen PE, Bygbjerg IC, Jakobsen PH, 2001. Distinguishing Plasmodium falciparum treatment failures from re-infections by using polymerase chain reaction (PCR) genotyping in an holoendemic area, northeastern Tanzania. Am J Trop Med Hyg 65: 477-483.
4. Daubersies P, Sallenave-Sales S, Magne S, Trape JF, Contamin H, Fandeur T, Rogier C, Mercereau-Puijalon O, Druilhe P, 1996. Rapid turn over of Plasmodium falciparum populations in asymptomatic individuals living in a high transmission area. Am J Trop Med Hyg 54: 18-26.
5. Färnert A, Snounou G, Rooth I, Björkman A, 1997. Daily dynamics of Plasmodium falciparum subpopulations in asymptomatic children in a holoendemic area. Am J Trop Med Hyg 56: 538-547.
6. Bruce MC, Galinski MR, Barnwell JW, Donnelly CA, Walmsley M, Alpers MP, Walliker D, Day KP, 2000. Genetic diversity and dynamics of Plasmodium falciparum and P. vivax populations in multiply infected children with asymptomatic malaria infections in Papua New Guinea. Parasitology 121: 257-272.
7. Druilhe P, Daubersies P, Patarapotikul J, Gentil C, Chene L, Chongsuphajaisiddhi T, Mellouk S, Langsley G, 1998. A primary malarial infection is composed of a very wide range of genetically diverse but related parasites. J Clin Invest 10: 2008-2016.
8. Färnert A, Tengstam K, Palme IB, Bronner U, Lebbad M, Swedberg G, Björkman A, 2002. Polyclonal Plasmodium falciparum malaria in travelers and selection of antifolate mutations after proguanil prophylaxis. Am. J Trop Med Hyg 66: 487-491.
9. Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN, 1993. Identification of the four human parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol Biochem Parasitol 58: 283-292.
10. Snounou G, Zhu X, Siripoon N, Jarra W, Thaithong S, Brown KN, Viriyakosol S, 1999. Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Trans R Soc Trop Med Hyg 93: 369-374.
11. Jafari S, Le Bras J, Bouchaud O, Durand R, 2004. Plasmodium falciparum clonal population dynamics during malaria treatment. J Infect Dis 189: 195-203.
12. James SP, Nicol WD, Shute PG, 1936. Clinical and parasitological observation on induced malaria. Proc R Soc Med 29: 879-894.
13. Collins WE, Jeffery GM, 1999. A retrospective examination of secondary sporozoite- and trophozoite-induced infections with Plasmodium falciparum: development of parasitologic and clinical immunity following secondary infection. Am J Trop Med Hyg 61 (Suppl): 20-35.